We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow % of AUM
Cap. Flow %
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.7
years
Top 20 Avg Time Held
Equity + Options
4.3
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1951
DELISTED
Apogee Therapeutics
APGE
| $2.36M | ﹤0.01% |
17,795
+4,164
| +31% | +$375K |
2025 Q2
4 quarters
|
|
1952
Garrett Motion
GTX
$4.02B
| $2.36M | ﹤0.01% |
65,173
+13,224
| +25% | +$368K |
2025 Q3
3 quarters
|
|
1953
Hertz
HTZ
$727M
| $2.35M | ﹤0.01% |
1,038,333
-176,519
| -15% | -$964K |
2023 Q4
10 quarters
|
|
1954
El Pollo Loco
LOCO
$439M
| $2.35M | ﹤0.01% |
138,480
+23,971
| +21% | +$343K |
2025 Q2
4 quarters
|
|
1955
WisdomTree
WT
$3.21B
| $2.33M | ﹤0.01% |
137,799
-4,966
| -3% | -$87.9K |
2024 Q4
6 quarters
|
|
1956
Legacy Housing
LEGH
$667M
| $2.33M | ﹤0.01% |
88,728
+38,980
| +78% | +$891K |
2026 Q1
1 quarter
|
|
1957
Navient
NAVI
$797M
| $2.32M | ﹤0.01% |
272,974
-38,518
| -12% | -$324K |
2023 Q2
12 quarters
|
|
1958
MarketAxess Holdings
MKTX
$5.8B
| $2.32M | ﹤0.01% |
20,448
-2,626
| -11% | -$374K |
2021 Q4
18 quarters
|
|
1959
Capitol Federal Financial
CFFN
$1.04B
| $2.32M | ﹤0.01% |
272,448
+7,826
| +3% | +$61.1K |
2013 Q2
52 quarters
|
|
1960
McGrath RentCorp
MGRC
$2.86B
| $2.32M | ﹤0.01% |
19,146
+7,426
| +63% | +$843K |
2023 Q4
10 quarters
|
|
1961
Organon & Co
OGN
$3.61B
| $2.32M | ﹤0.01% |
171,053
+92,011
| +116% | +$1.1M |
2021 Q2
20 quarters
|
|
1962
American Healthcare REIT
AHR
$11.6B
| $2.31M | ﹤0.01% |
44,386
+648
| +1% | +$31.8K |
2024 Q3
7 quarters
|
|
1963
iShares US Financials ETF
IYF
$3.82B
| $2.31M | ﹤0.01% |
18,140
-2,666
| -13% | -$331K |
2015 Q3
43 quarters
|
|
1964
OneSpan
OSPN
$744M
| $2.31M | ﹤0.01% |
161,011
+63,203
| +65% | +$799K |
2023 Q4
10 quarters
|
|
1965
New Jersey Resources
NJR
$5.39B
| $2.31M | ﹤0.01% |
41,222
+16,049
| +64% | +$898K |
2015 Q3
43 quarters
|
|
1966
Axalta
AXTA
$7.31B
| $2.31M | ﹤0.01% |
67,488
-58,997
| -47% | -$1.77M |
2023 Q4
10 quarters
|
|
1967
Legend Biotech
LEGN
$3.75B
| $2.31M | ﹤0.01% |
79,946
+24,929
| +45% | +$672K |
2024 Q4
6 quarters
|
|
1968
Avantis International Large Cap Value ETF
AVIV
$2.03B
| $2.3M | ﹤0.01% |
29,679
-60
| -0.2% | -$4.69K |
2023 Q1
13 quarters
|
|
1969
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.9B
| $2.29M | ﹤0.01% |
44,703
+8,219
| +23% | +$421K |
2023 Q2
12 quarters
|
|
1970
ProShares S&P 500 ex-Technology ETF
SPXT
$301M
| $2.29M | ﹤0.01% |
21,178
+1,873
| +10% | +$201K |
2021 Q4
18 quarters
|
|
1971
Envista
NVST
$3.79B
| $2.29M | ﹤0.01% |
86,858
+16,107
| +23% | +$406K |
2023 Q4
10 quarters
|
|
1972
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.95B
| $2.28M | ﹤0.01% |
49,989
+12,082
| +32% | +$553K |
2025 Q2
4 quarters
|
|
1973
Spyre Therapeutics
SYRE
$8.44B
| $2.28M | ﹤0.01% |
25,713
+10,227
| +66% | +$746K |
2026 Q1
1 quarter
|
|
1974
State Street SPDR S&P Semiconductor ETF
XSD
$2.59B
| $2.27M | ﹤0.01% |
3,647
+81
| +2% | +$42.4K |
2021 Q2
20 quarters
|
|
1975
Albany International
AIN
$1.78B
| $2.27M | ﹤0.01% |
30,524
+4,604
| +18% | +$289K |
2025 Q3
3 quarters
|
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.